# Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease

> **NCT00975195** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 2488 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** tiotropium inhalation
- **DRUG:** salmeterol xinafoate
- **DRUG:** fluticasone propionate
- **DRUG:** placebo matched for fluticasone propionate

## Key facts

- **NCT ID:** NCT00975195
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 2488 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975195, "Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00975195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*